Follow
Matthew G Booty
Matthew G Booty
Takeda
Verified email at takeda.com
Title
Cited by
Cited by
Year
STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus
EF Remmers, RM Plenge, AT Lee, RR Graham, G Hom, TW Behrens, ...
New England Journal of Medicine 357 (10), 977-986, 2007
13462007
An autoinflammatory disease with deficiency of the interleukin-1–receptor antagonist
I Aksentijevich, SL Masters, PJ Ferguson, P Dancey, J Frenkel, ...
New England Journal of Medicine 360 (23), 2426-2437, 2009
10832009
Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis
SM Behar, CJ Martin, MG Booty, T Nishimura, X Zhao, HX Gan, ...
Mucosal immunology 4 (3), 279-287, 2011
5372011
In search of a new paradigm for protective immunity to TB
C Nunes-Alves, MG Booty, SM Carpenter, P Jayaraman, AC Rothchild, ...
Nature Reviews Microbiology 12 (4), 289-299, 2014
4202014
Familial mediterranean fever with a single MEFV mutation: Where is the second hit?
MG Booty, JJ Chae, SL Masters, EF Remmers, B Barham, JM Le, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
3572009
Efferocytosis is an innate antibacterial mechanism
CJ Martin, MG Booty, TR Rosebrock, C Nunes-Alves, DM Desjardins, ...
Cell host & microbe 12 (3), 289-300, 2012
3352012
Inflammatory signaling in human tuberculosis granulomas is spatially organized
MJ Marakalala, RM Raju, K Sharma, YJ Zhang, EA Eugenin, B Prideaux, ...
Nature medicine 22 (5), 531-538, 2016
3292016
Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis
BB Mishra, RR Lovewell, AJ Olive, G Zhang, W Wang, E Eugenin, ...
Nature microbiology 2 (7), 1-11, 2017
2822017
Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein
JG Ryan, SL Masters, MG Booty, N Habal, JD Alexander, BK Barham, ...
Annals of the rheumatic diseases 69 (7), 1360-1363, 2010
1132010
IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission
JG Ryan, HD De Koning, LA Beck, MG Booty, DL Kastner, A Simon
Journal of Allergy and Clinical Immunology 121 (1), 260-262, 2008
1072008
Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus
SM Behar, SM Carpenter, MG Booty, DL Barber, P Jayaraman
Seminars in immunology 26 (6), 559-577, 2014
802014
A Higher Activation Threshold of Memory CD8+ T Cells Has a Fitness Cost That Is Modified by TCR Affinity during Tuberculosis
SM Carpenter, C Nunes-Alves, MG Booty, SS Way, SM Behar
PLoS pathogens 12 (1), e1005380, 2016
552016
IL-21 signaling is essential for optimal host resistance against Mycobacterium tuberculosis infection
MG Booty, P Barreira-Silva, SM Carpenter, C Nunes-Alves, MK Jacques, ...
Scientific reports 6 (1), 36720, 2016
482016
Human and murine clonal CD8+ T cell expansions arise during tuberculosis because of TCR selection
C Nunes-Alves, MG Booty, SM Carpenter, AC Rothchild, CJ Martin, ...
PLoS pathogens 11 (5), e1004849, 2015
392015
Microarray-based gene expression profiling in patients with cryopyrin-associated periodic syndromes defines a disease-related signature and IL-1-responsive transcripts
JE Balow Jr, JG Ryan, JJ Chae, MG Booty, A Bulua, D Stone, HW Sun, ...
Annals of the rheumatic diseases 72 (6), 1064-1070, 2013
382013
Nitric oxide prevents a pathogenpermissive granulocytic inflammation during tuberculosis. Nat Microbiol 2: 17072
BB Mishra, RR Lovewell, AJ Olive, G Zhang, W Wang, E Eugenin, ...
232017
Multiple inflammatory cytokines converge to regulate CD8+ T cell expansion and function during tuberculosis
MG Booty, C Nunes-Alves, SM Carpenter, P Jayaraman, SM Behar
The Journal of Immunology 196 (4), 1822-1831, 2016
232016
Microfluidic squeezing enables MHC class I antigen presentation by diverse immune cells to elicit CD8+ T cell responses with antitumor activity
MG Booty, KA Hlavaty, A Stockmann, EI Ozay, C Smith, L Tian, E How, ...
The Journal of Immunology 208 (4), 929-940, 2022
152022
141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL …
M Booty, A Stockmann, O Pryor, M Myint, C Trumpfheller, V Nicolini, ...
Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020
42020
Engineering a new generation of cell therapies for solid tumor oncology using the SQZ platform
KA Hlavaty, MG Booty, S Loughhead, K Blagovic, A Vicente-Suarez, ...
Cancer Research 79 (13_Supplement), 3187-3187, 2019
42019
The system can't perform the operation now. Try again later.
Articles 1–20